当前位置: X-MOL 学术Oncol. Rep. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
[Retracted] CXCL5 promotes the proliferation and migration of glioma cells in autocrine‑ and paracrine‑dependent manners.
Oncology Reports ( IF 3.8 ) Pub Date : 2021-08-09 , DOI: 10.3892/or.2021.8163
Zhijie Dai 1 , Jun Wu 2 , Fenghua Chen 2 , Quan Cheng 2 , Mingyu Zhang 2 , Ying Wang 2 , Yong Guo 2 , Tao Song 2
Affiliation  

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the western blotting assay data shown in Fig. 7 were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive any reply. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 36: 3303-3310, 2016; DOI: 10.3892/or.2016.5155].

中文翻译:

[已撤稿] CXCL5 以自分泌和旁分泌依赖性方式促进神经胶质瘤细胞的增殖和迁移。

在这篇论文发表后,一位关注的读者引起了编辑的注意,图 7 中显示的某些蛋白质印迹分析数据与不同作者在其他文章中以不同形式出现的数据惊人地相似。由于上述文章中有争议的数据在提交给肿瘤学报告之前已经在其他地方发表,或者已经在考虑发表,编辑决定从期刊撤回这篇论文。作者被要求解释这些担忧,但编辑部没有收到任何答复。给读者带来的不便,编者深表歉意。【原文发表于 Oncology Reports 36: 3303-3310, 2016;DOI:10.3892/或.2016.5155]。
更新日期:2021-08-09
down
wechat
bug